Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-01-22

Clinical Trial Update: Platelet-Rich Plasma in Acute Muscle Injuries [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on the use of Platelet-Rich Plasma for acute muscle injuries has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Platelet-rich plasma (platelet-rich plasma)

Snippet

Sponsor: University of the Basque Country (UPV/EHU) | Conditions: Muscle Injury | Phase 2 | Status: COMPLETED